NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I Study

CompletedN/A

Sponsor: Latin American Cooperative Oncology Group

Conditions: Cervix Cancer

Interventions: Quality of Life Questionnaire (QLQ)

Countries: Brazil

The primary objective of this study is to describe the socio-demographic, clinical pathological, quality of life and treatment characteristics of patients diagnosed with CC in Brazil.

Eligibility overview

Sex: FEMALE

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Histologic confirmed invasive cervical cancer
* Diagnosis of FIGO stages
* Stage 1B to 2A high risk
* 2B-4B or recurrent disease
* Patients ≥18 years old

Exclusion Criteria:

1. Non-invasive uterine carcinoma;
2. Pregnancy;
3. synchronous tumor or second primary tumor in the past 5 years (except thyreoid ancer or non-melanoma skin cancer).

Locations (16)

Manaus, Amazonas, Brazil
Fortaleza, Ceará, Brazil
Salvador, Estado de Bahia, Brazil
Ceará, Fortaleza, Brazil
São Luís, Maranhão, Brazil
Belo Horizonte, Minas Gerais, Brazil
Curitiba, Paraná, Brazil
Recife, Pernambuco, Brazil
Passo Fundo, Rio Grande do Sul, Brazil
Porto Alegre, Rio Grande do Sul, Brazil
Boa Vista, Roraima, Brazil
Florianópolis, Santa Catarina, Brazil
Itajaí, Santa Catarina, Brazil
Rio de Janeiro, Brazil
São Paulo, Brazil
São Paulo, Brazil